Haya Taitel - 07 Aug 2026 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Reporting relationship: Director
Issuer ticker: ENTX
Reported as of: 07 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Aug 2026, 16:22:24 UTC
Prior SEC filing: 11 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Dana Yaacov-Garbeli, Attorney-in-Fact

Key filing fact

Haya Taitel filed Form 4 for Entera Bio Ltd. (ENTX) on 07 Aug 2026.

Key facts

This page summarizes Haya Taitel's Form 4 filing for Entera Bio Ltd. (ENTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Aug 2026, 16:22.

Change

Previous filing in this sequence was filed on 11 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001979599 Primary reporting owner

Taitel Haya

Relationship: Director
Address: KIRYAT HADASSAH, MINRAV BUILDING, 5TH FLOOR, JERUSALEM, ISRAEL
Signature: /s/ Dana Yaacov-Garbeli, Attorney-in-Fact
Signature date: 07 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENTX transaction

Ordinary Shares, par value NIS 0.0000769 per share

Award

Transaction value
Shares: +20,790
Change %: +21%
Price: $0.000000^*
Shares after: 119,269
Date: 07 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") awarded these shares to the Reporting Person in lieu of the cash fees the Reporting Person was entitled to for services rendered as a director of the Company for the first quarter and second quarter of 2026. This grant of shares was approved by the Board on August 5, 2026, subject to the filing by the Company of a Registration Statement on Form S-8 registering the shares, which occurred on August 7, 2026.